Kangso Medical Inspection was founded in 2010 and got Ministry of Health P.R. China certificated in March 6, 2012.

Kangso Medical Inspection and its whole-owned subsidiary, Huakang Gene Institute, carry diverse responsibilities on clinical molecular genetics, specifically on the detection of virulence gene of genetic disease and non-invasive prenatal diagnosis. Our IR&D Bestseq is the most accurate, economic and efficient targeted gene capture sequencing technology based on NGS.

At present, we are working with China’s top-ranked hospitals in the detection of more than 400 genetic diseases. Rather than testing single genes, we have genetic testing panels covering Hereditary Cardiovascular Diseases, Genetic Endocrine and Metabolic Diseases, Genetic Nervous System Diseases, Hereditary Eye Diseases, Genetic Skin Diseases and Germline Cancer.